Royal Bank of Canada
NVAX icon

Royal Bank of Canada’s Novavax NVAX Stock Holding History

Royal Bank of Canada’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-200
Closed -$1K – 6977
2019
Q2 		$1K Buy
200
+145
+264% +$1.14K ﹤0.01% 6725
2019
Q1 		$1K Buy
+55
New +$1.74K ﹤0.01% 6668

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royal Bank of Canada's NVAX Position: Q1 2026 in Review

Royal Bank of Canada reduced its Novavax (NVAX) stake by 14% in Q1 2026, selling an estimated $19.1K and leaving 13,487 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #5067.

Royal Bank of Canada first reported a position in NVAX in Q2 2013 and has held it in 52 quarters since. The position peaked at $14.5M in Q3 2021. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Royal Bank of Canada held 13,487 shares of Novavax worth $110K as of Q1 2026.
  • Royal Bank of Canada sold 2,106 Novavax shares in Q1 2026, an estimated $19.1K.
  • Novavax made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5067 holding.
  • Royal Bank of Canada first reported a position in Novavax in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Novavax position peaked at $14.5M in Q3 2021.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.